📰 Athersys Inc News
Page 11 - Athersys Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Athersys Inc. Real-time updates on events, politics, business and more.
May 1, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today their participation in the Cellular Therapeutics in Trauma and Critical Care’s (CTTACC) conference, “Cellular Therapies and Tran...
April 21, 2023
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today their participation in The American Society for Neural Therapy... | April 21, 2023
April 20, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX) today announced that it has closed its previously announced offering to sell 3,685,000 shares (the “Shares”) of the Company’s common stock (or common stock equivalents in lieu thereof) in a registered direct offering and warrants to purchase 3,685,000 Shares...
April 18, 2023
Athersys, Inc. today announced that it has entered into definitive agreements for the purchase and sale of 3,685,000 shares of the Company’s common stock in a registered direct offering and... | April 18, 2023
April 18, 2023
April 18, 2023 Athersys, Inc. Attention: Mr. Daniel Camardo 3201 Carnegie Avenue Cleveland, Ohio 44115 Dear Mr.... | April 18, 2023
April 12, 2023
/PRNewswire/ -- The cell therapy market size is forecasted to increase by USD 21.061 billion from 2021 to 2026, at a CAGR of 56.79%, according to the recent...
April 10, 2023
Athersys, Inc. , a cell therapy and regenerative medicine company developing MultiStem® for critical care indications, announced today it will host a business update conference call on April 20,... | April 10, 2023
April 10, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a business update conference call on April 20, 2023 at 11:00 a.m. Eastern Time. Dan Camardo, Chief Executive Of...
March 31, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ... | March 31, 2023
March 28, 2023
/PRNewswire/ -- The "Global Market for Stem Cells" report has been added to ResearchAndMarkets.coms offering. This report discusses the implications of stem...